ATM and prostate neoplasm: In addition, Andrographolide decreased prostate tumor growth, decreased matrix metalloproteinase 11 (MMP11) expression, decreased angiogenesis and altered DNA repair genes such as BRCA2, ATM, BRIP1 in vivo.